Repligen Corp
Current role
RGEN
Karen A. Dawes
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Karen A. Dawes
Repligen Corp reported in an 8-K filed September 15, 2026 that Karen A. Dawes retired as Board of Directors, effective September 30, 2026. Repligen Corp reported in an 8-K filed June 14, 2024 that Karen A. Dawes was appointed Lead Independent Director, effective September 1, 2024.
“On September 10, 2026, Karen A. Dawes notified Repligen Corporation ("Repligen") that she will be retiring from the Repligen Board of Directors (the "Board") after over twenty years of distinguished service to Repligen, effective as of September 30, 2026.”
“appointed Karen A. Dawes, the Board's current Chair, to the role of Lead Independent Director, each effective as of the Transition Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Repligen Corp (RGEN)
SEC 8-K
Current2024-09-01–present
-
Start not stated–2026-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Repligen Corp
Other people whose current roles at this company are on record from its filings.
- Olivier Loeillot CEO, Board Member
- Dr. Martin D. Madaus Chairman, Board Member
- Martin D. Madaus Chairman
- Tony J. Hunt Chairman
- Jason Garland CFO
- Jason K. Garland CFO, Chief Accounting Officer
- James Bylund COO
- Violetta Hughes Chief Accounting Officer
- Carrie Eglinton Manner Board Member
- Glenn P. Muir Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.